Cancer Research & Education
Genentech BioOncology is dedicated to fostering future progress in anticancer innovations by sharing the latest advances in cancer research.
Click on one of our research sites below to learn more about exciting areas of cancer exploration.
Find out more about a new generation of antibody drug conjugates (ADCs).
Learn more about apoptosis and its role in cancer.
Discover the ongoing developments in B-cell malignancies and access educational resources.
Oncogenic BRAF signaling is implicated in diverse malignancies. Learn more about BRAF-mediated signaling and the potential of BRAF as a novel therapeutic target.
Research Cancer Immunotherapy
Learn more about the potential of PD-L1 inhibition and cancer immunotherapy.
HER receptor dimerization is implicated in tumor growth and tumor survival in preclinical models. Learn more about dimerization's role in HER2+ breast cancer and the potential for inhibition.
Research HER Pathways
Discover more about the human epidermal growth factor receptor (HER) family and its role in tumorigenesis.
The MET pathway is dysregulated in many malignancies. Discover more about MET signaling and the potential for targeting the MET pathway in cancer.
The PI3K signaling pathway regulates cell survival, proliferation, and growth. Learn more about the potential benefits of PI3K pathway inhibitors and their role in advancing cancer therapy.
Learn about the role of vascular endothelial growth factor (VEGF) in angiogenesis and its relationship to cancer.